#1 Clinical Trials Search in Europe

Betamethasone Valerate

Betamethasone Valerate, a potent corticosteroid, has been extensively studied in clinical trials for its effectiveness in treating various skin conditions. This article explores the use of Betamethasone Valerate in clinical trials, focusing on its applications in atopic eczema, hand eczema, psoriasis, and other dermatological disorders. We’ll examine its efficacy, safety profile, and comparison with other treatments.

Table of Contents

What is Betamethasone Valerate?

Betamethasone valerate is a topical corticosteroid medication used to treat various skin conditions. It belongs to a class of drugs known as corticosteroids, which are synthetic versions of hormones naturally produced by the body[1]. Corticosteroids like betamethasone valerate work by reducing inflammation and suppressing the immune system’s response in the affected area.

This medication is available under different brand names, including:

  • Betnoderm 0,1% krӓm[1]
  • Betnovat krӓm 0,1%[1]
  • Celestone-M[2]

Conditions Treated with Betamethasone Valerate

Betamethasone valerate is used to treat various skin conditions characterized by inflammation, itching, and redness. Some of the conditions it can help manage include:

  1. Atopic Eczema: A chronic, itchy skin condition often associated with dry skin[1].
  2. Hand Eczema: A specific type of eczema affecting the hands[3].
  3. Plaque Type Psoriasis: A condition causing red, scaly patches on the skin[2].
  4. Discoid Lupus Erythematosus: An autoimmune condition causing coin-shaped lesions on the skin, particularly on the face[4].
  5. Paronychia: An infection of the skin around the nails, which can be a side effect of certain cancer treatments[5].

Formulations and Usage

Betamethasone valerate is available in various formulations, including:

  • Cream (0.1% concentration)[1]
  • Lotion[5]
  • Ointment[6]

The medication is typically applied topically (directly on the skin) to the affected areas. The frequency of application can vary depending on the condition being treated and the doctor’s instructions. In many cases, it is applied once or twice daily[3].

Effectiveness of Betamethasone Valerate

Betamethasone valerate has been shown to be effective in managing various skin conditions. Its effectiveness is often compared to other treatments in clinical trials:

  • In treating atopic eczema, it has been used as a reference medication to compare the effectiveness of new formulations[1].
  • For hand eczema, it has been studied as part of a treatment regimen to clear eczema and prevent recurrence[3].
  • In psoriasis treatment, it has been used as a comparator to evaluate the efficacy of new medications[2].
  • For discoid lupus erythematosus, it has been compared to other treatments like pimecrolimus cream[4].

Potential Side Effects

While betamethasone valerate is generally considered safe when used as directed, it can cause some side effects, especially with long-term use. Potential side effects may include:

  • Skin thinning (atrophy): Prolonged use can lead to thinning of the skin in the treated area[4].
  • Telangiectasia: Visible small blood vessels near the surface of the skin[6].
  • Striae distensae: Also known as stretch marks[6].
  • Folliculitis: Inflammation of hair follicles[6].
  • Contact dermatitis: An allergic reaction to the medication[6].
  • Acne or rosacea: In some cases, it may trigger or worsen these conditions[6].

The risk of side effects can depend on factors such as the potency of the formulation, the area of application, the patient’s age, and the duration of use[6].

Ongoing Research and Clinical Trials

Researchers continue to study betamethasone valerate to better understand its efficacy and safety profile in various conditions:

  • A study is comparing the effects of betamethasone valerate cream to crisaborole ointment on skin structure and function in people with atopic dermatitis[6].
  • Another trial is investigating the use of betamethasone valerate in combination with topical timolol for treating paronychia caused by certain cancer treatments[5].
  • Researchers are also exploring its use in comparison to other treatments for conditions like plaque psoriasis and discoid lupus erythematosus[2][4].

These ongoing studies aim to provide more information about the best ways to use betamethasone valerate and how it compares to other treatments for various skin conditions.

Condition Betamethasone Valerate Formulation Key Findings
Atopic Eczema 0.1% cream Used as a reference treatment to compare skin tolerance and efficacy of new formulations
Hand Eczema 0.1% cream Applied once or twice daily for two weeks to assess clearance of hand eczema
Paronychia 0.1% lotion/cream Used as a standard treatment, compared with combination therapy including timolol
Plaque Psoriasis 0.02% cream Used as a reference treatment in comparison with new topical formulations
Oral Submucous Fibrosis 0.1% lotion Applied topically as part of conventional management, compared with alternative treatments
Discoid Lupus Erythematosus 0.1% cream Compared with pimecrolimus 1% cream for efficacy and safety in facial lesions

FAQ

  • What is Betamethasone Valerate used for in clinical trials? Betamethasone Valerate is used in clinical trials to treat various skin conditions including atopic eczema, hand eczema, psoriasis, oral submucous fibrosis, and discoid lupus erythematosus. It's often used as a comparator to test the efficacy of new treatments.
  • How is Betamethasone Valerate typically applied in these trials? In most trials, Betamethasone Valerate is applied topically as a cream or lotion. The typical concentration is 0.1%, and it's usually applied once or twice daily for a specified period, often ranging from a few weeks to several months.
  • What are the potential side effects of Betamethasone Valerate? Potential side effects of Betamethasone Valerate include skin thinning, telangiectasia (small dilated blood vessels near the surface of the skin), and in some cases, skin atrophy. Long-term use may lead to more significant side effects.
  • How does Betamethasone Valerate compare to other treatments in clinical trials? Betamethasone Valerate is often used as a reference treatment to compare the efficacy of new drugs. In some trials, it has shown comparable or better results than newer treatments, while in others, alternative treatments have demonstrated similar or superior efficacy with potentially fewer side effects.
  • Is Betamethasone Valerate safe for long-term use? While Betamethasone Valerate is effective for short-term use, long-term application can lead to side effects such as skin thinning. Clinical trials often explore alternatives or combination therapies to minimize these risks while maintaining efficacy.

Ongoing Clinical Trials on Betamethasone Valerate

  • Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Comparing pivmecillinam and gentamicin with standard treatments for hospitalized adults with complicated urinary tract infections

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study of pivmecillinam compared to standard antibiotics for treating Escherichia coli urinary tract infection with fever

    Recruiting

    1 1 1
    Investigated drugs:
    Norway Sweden

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Norway

  • Study on Betamethasone Sodium Phosphate and Drug Combination for Pregnant Women with Preterm Premature Rupture of Membranes

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Aztreonam-Avibactam and Metronidazole for Children with Serious Gram-Negative Bacterial Infections

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Greece Hungary Spain

  • Study of antibiotic treatment effectiveness in critically ill patients receiving drug combination therapy

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on Dupilumab Step-Down Strategy for Maintaining Remission in Adults and Adolescents with Atopic Dermatitis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Finland Germany Norway Poland

Glossary

  • Atopic Eczema: A chronic, itchy skin condition that often starts in childhood. It's characterized by dry, red, and inflamed skin.
  • Paronychia: An infection of the skin around the fingernails or toenails, often caused by injury or excessive exposure to moisture.
  • Topical: Referring to a medication or treatment applied directly to the skin.
  • Corticosteroid: A class of steroid hormones that reduce inflammation in the body. Betamethasone Valerate is a synthetic corticosteroid.
  • Plaque Psoriasis: The most common form of psoriasis, characterized by raised, red patches covered with a silvery white buildup of dead skin cells.
  • Discoid Lupus Erythematosus: A chronic skin condition characterized by inflamed, scaly patches on the face, ears, and scalp and at times on other body areas.
  • EGFR-TKI: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, a type of targeted therapy used in cancer treatment.
  • ALK-TKI: Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor, another type of targeted therapy used in cancer treatment.
  • Oral Submucous Fibrosis: A chronic, progressive condition affecting the mouth and sometimes the throat, characterized by inflammation and stiffness of the mucous membranes.

References

  1. https://clinicaltrials.gov/study/NCT00576238
  2. https://clinicaltrials.gov/study/NCT01646567
  3. https://clinicaltrials.gov/study/NCT00576550
  4. https://clinicaltrials.gov/study/NCT00608673
  5. https://clinicaltrials.gov/study/NCT06140186
  6. https://clinicaltrials.gov/study/NCT04194814